Obesity Trial, Recruiting NCT06867354 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06867354
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been on a breathing machine (mechanical ventilator) for at least 48 hours
  • People who are on a ventilator setting that allows them to take some breaths on their own, with the machine providing support, and where the breath size and pressure settings fall within specific ranges
  • People whose doctor has decided they are ready to try a "spontaneous breathing trial" — a test to see if they can breathe without the ventilator — after meeting a set of medical readiness checks, including stable oxygen levels, heart rate, blood pressure, breathing rate, and little or no need for blood pressure-supporting medications
  • People (or their family member, if the person cannot respond) who have been informed about the study and have not objected to taking part
  • People who are covered by, or eligible for, a social security scheme (French healthcare coverage)
  • People with a body mass index (BMI) above 30 kg/m² — meaning they are classified as obese — for those being enrolled in the specific obesity group of the trial

Who may not be able to join:

  • People under 18 years of age
  • Women who are pregnant or breastfeeding
  • People for whom coming off the ventilator is not considered possible, such as those with pre-existing muscle or nerve disorders, or injuries to the upper spinal cord in the neck area
  • People for whom repeatedly assessing feelings of breathlessness would likely be difficult, such as those with a known history of cognitive or psychiatric conditions, those currently experiencing delirium, or those with a level of sedation or agitation outside a specific range
  • People who are under a legal protection order, such as guardianship or curatorship

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 00 33 6 23 08 64 88

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 March 2025
Est. completion
1 March 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Presence or onset of dyspnea

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov